Research On Financial Risk Identification And Evaluation Of G Pharmaceutical Enterprises

With the deepening of the aging degree of China’s society and the increasing improvement of the national living standards,the people’s health awareness is gradually increasing.As a pillar industry,related to people’s health and the quality of People’s Daily life,is the guarantee of the long-term stability of the country.In recent years,under the strong support of national policy,pharmaceutical manufacturing rapid development,as the world’s fastest developing,one of the most competitive industry,to face from internal or external various financial risk,therefore,attach importance to the financial risk identification and establish a scientific and effective evaluation system for enterprises and even industry has extremely important practical significance.As a pharmaceutical manufacturing enterprise with an early listing and a large scale in China,G pharmaceutical enterprise has a certain reputation and representativeness in the industry.This thesis selects G pharmaceutical enterprise as a research case to identify and evaluate its financial risks and put forward preventive measures.first,The industry background and business situation of G pharmaceutical enterprises are expounded,Combined with the financial statement data of G Pharmaceutical enterprises from 2017 to 2021,Based on the identification and cause analysis of financial risk from the four perspectives of debt repayment risk,profit risk,operating risk and development risk,Clarify the necessity of establishing the financial risk evaluation system;next,Starting from the relevant theory of financial risk evaluation,The modified efficacy coefficient method combined with the entropy method was chosen,The importance of the financial risk of G pharmaceutical enterprises has been vertically evaluated in the past five years,And the F scoring model based on the modified Z-value model of the multivariate linear correlation model,The financial statement data of two enterprises in the same industry are selected to horizontally evaluate the financial risk of the enterprise in the past five years,The comparative evaluation results are obtained;last,Combined with the actual situation of G pharmaceutical enterprises and the comprehensive evaluation conclusion of financial risks,G pharmaceutical enterprises to prevent financial risks.The research in this thesis is conducive to the enterprise effectively identify the financial risk,timely measure the importance of financial risk,so as to avoid the importance of high financial risk,industry competitiveness,healthy development for the enterprise,at the same time,also can for other pharmaceutical manufacturing enterprises in the financial risk management to provide effective thinking and reference significance.